UPDATE 1-Two experimental Ebola vaccines pass safety test in African trial
March 26, 2015 at 18:15 PM EDT
NEW YORK, March 26 (Reuters) - Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said on Thursday.